SLC10A1 and coronary artery disorder: The hepatic levels of the Na+/BA-cotransporter Slc10a1 were significantly higher in NOD1 KO vs. WT mice in CHD regimen, suggesting that the enterohepatic circulation of BA into hepatocytes was reduced upon HFD treatment.